Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Series C
Portfolio 34
| Date | Name | Website | Total Raised | Location |
| 24.12.2023 | Serpex Med... | serpexmedical.mystrikingly.com | - | - |
| 15.03.2023 | Shoulder I... | shoulderinnovations.com | $67.6M | United Sta... |
| 14.05.2022 | XII Medica... | xiimedical.com | $30M | - |
| 12.03.2022 | Nalu Medic... | nalumed.com | $299M | United Sta... |
| 29.01.2022 | PetDx | petdx.com | $62M | United Sta... |
| 10.10.2021 | Devoro Med... | devoromedical.com | - | - |
| 30.07.2021 | uLab Syste... | ulabsystems.com | $60.5M | United Sta... |
| 14.07.2016 | Endotronix | endotronix.com | $159M | United Sta... |
| - | Otonomy, I... | otonomy.com | $143.9M | United Sta... |
| - | ShiraTroni... | shiratronics.com | $102M | United Sta... |
Show more
Mentions in press and media 17
| Date | Title | Description |
| 15.10.2024 | ShiraTronics: A New Dawn for Chronic Migraine Sufferers | Chronic migraines are like shadows that loom over millions, darkening their days and stealing their joy. For those who suffer, the search for relief can feel like an endless journey through a fog. Enter ShiraTronics, a beacon of hope in thi... |
| 09.10.2024 | ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine | Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage medical ... |
| 12.03.2024 | Venus Concept Launches “NEXThetics” Program | New Venus AI Event Series Focused on Enhancing Customer Education and Training TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic ... |
| 07.01.2021 | Cortica Raises $60M to Expand Comprehensive Autism Care Model Nationwide | What You Should Know: – Cortica, Inc. (“Cortica”), a San Diego, CA-based tech-enabled clinical services for autism and other neurodevelopmental conditions, announced it has raised $60 million in financing to further its mission to transform... |
| 19.02.2020 | Endotronix Enrolls First Patients in PROACTIVE-HF Pivotal Trial | LISLE, Ill. /PRNewswire/ — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), today announced the enrollment of the first two patients in the PROACTIVE-HF pivotal ... |
| 01.10.2019 | Endotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution | LISLE, IL – Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D financing round, bringing the total for the round to $70 million. The ... |
| 14.09.2018 | Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure | Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million. The round was led by LSP, investing from its LSP Health... |
| 26.04.2018 | Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure | KIRKLAND, Wash.–(BUSINESS WIRE)– Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with heart failure, today announced the company has closed a $39 million Series B financing. The roun... |
| 17.07.2016 | Endotronix Raises $32M Series C from Aperture Venture Partners | Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, announced that the company has closed a $32 million Series C round of financing. The investor syndicate brings toget... |
| 17.07.2016 | Endotronix Raises $32M Series C from BioVentures Investors | Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, announced that the company has closed a $32 million Series C round of financing. The investor syndicate brings toget... |
Show more